Loading...
Loading...
NEW YORK, NY · CIK 0001263508
Portfolio Value
$17.63B
Positions
117
New
5
Increased
24
Decreased
7
Sold Out
6
BAKER BROS. ADVISORS LP (NEW YORK, NY) reported a portfolio value of $17.63B across 117 positions in their Q2 2022 SEC 13F filing (period ending 2022-06-30). The top 10 positions account for 87.5% of the portfolio.
Top 30 holdings by portfolio weight. Block width = holding percentage. Green = new/increased, red = reduced, gray = unchanged.
| # | Stock | Value↓ | Weight | Change |
|---|---|---|---|---|
| 1 | SGENUSDSeagen Inc. | $8.30B | 47.09% | - |
| 2 | INCYIncyte Corporation | $2.75B | 15.58% | +0.0% |
| 3 | ONCBeiGene, Ltd. | $1.89B | 10.71% | - |
| 4 | BMRNBioMarin Pharmaceutical Inc. | $631.51M | 3.58% | - |
| 5 | ACADACADIA Pharmaceuticals Inc. | $590.70M | 3.35% | +0.0% |
| 6 | ASNDUSDAscendis Pharma A/S | $451.10M | 2.56% | +6.8% |
| 7 | ARGXargenx SE | $424.18M | 2.41% | - |
| 8 | BCRXBioCryst Pharmaceuticals, Inc. | $134.48M | 0.76% | - |
| 9 | KODKodiak Sciences Inc. | $132.25M | 0.75% | +8.7% |
| 10 | GBTUSDGlobal Blood Therapeutics, Inc. | $119.25M | 0.68% | +12.6% |
| Stock | Value | Shares |
|---|---|---|
| ATRAGBXAtara Biotherapeutics, Inc. | $5.80M | 744,186 |
| VORVor Biopharma Inc. | $5.66M | 1,138,768 |
| NKTXNkarta, Inc. | $4.93M | 400,000 |
| NTRANatera, Inc. | $3.54M | 100,000 |
| 1AQEvofem Biosciences, Inc. | $2.92M | 2,583,616 |
Get alerts when BAKER BROS. ADVISORS LP files new 13F holdings.